Mysimba 8 mg/90 mg prolonged-release tablets
Approved small_molecule active
Quick answer
Mysimba 8 mg/90 mg prolonged-release tablets for Obesity, Obesity Surgery is a Approved program (small_molecule) at Disc Medicine with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Disc Medicine
- Indication
- Obesity, Obesity Surgery
- Phase
- Approved
- Modality
- small_molecule
- Status
- active